We would love to hear your thoughts about our site and services, please take our survey here.
This will not go away, unless the paitents are treated properly and the infections is killed. Information and Research shows that is main aim of the TILS treatment, to clear the infection once it has reached the lungs, if not fully cleared it flares up again in the future.
GENEVA (Reuters) - The World Health Organization (WHO) said on Saturday that it was looking into reports of some COVID-19 patients testing positive again after initially testing negative for the disease while being considered for discharge.
South Korean officials on Friday reported 91 patients thought cleared of the new coronavirus had tested positive again. Jeong Eun-kyeong, director of the Korea Centers for Disease Control and Prevention, told a briefing that the virus may have been “reactivated” rather than the patients being re-infected.
Latino , et all. Also just found out that Synairgen (SNG) treatment is not for Covid-19. It is for Asthma patients with cold or flu infection. Covid-19 is not flu. Not sure how this will help Covid-19 patients. More research required.
Howeber, the research on TILS shows that their treatment has direct impact on very specific Covid-19 infection protien, which has cuased the excitement within the company and forced them to patent it quickly before starting testing. This seems to be the real deal and a home run.
iamrich, i replied to you on the main TILS baord. see below -mind the spellling! (price may flatcuate as low flaot in the end it will be huge, as early indications are strong and company board very exiting and very busy)
iamrich - they have found it worked in china and napels, if you see the CEO and Chief Scientist interviews, you will see it has taken the compnay by suprise, that they were sitting on gold mine which they acquired from swiss compnay back in 2017. In layman terms their drug treatment acts on the very protiens created by Covid-19 infections (proven by Roches drug trails on mouse). Now here is the thing TILLS treatement is human ready, i.e. has been used in humans and does not need to be tested in mouse/monkeys before give to humans, so there less complications right of the bat) - what needs to happen now is for them to deliver this treatment to Covid-19 paitents direct to the lungs to reduce the spread and kill of the virus as it develops in the lungs. When the virus gets into the lungs thats when pietents become very ill and start de-teriating leading to death. Very excited by TILLS, and Alan Green was spot on when he recommended by on Vax a few weeks ago.
The rest is in the posts below. do some dd. there will alot of rubbish from major boy (who is disrupting the board) - so filter him and you will see all good posts. hope that helps. glta.
iamrich - they have found it worked in china and napels, if you see the CEO and Chief Scientist interviews, you will see it has taken the compnay by suprise, that they were sitting on gold mine which they acquired from swiss compnay back in 2017. In layman terms their drug treatment acts on the very protiens created by Covid-19 infections (proven by Roches drug trails on mouse). Now here is the thing TILLS treatement is human ready, i.e. has been used in humans and does not need to be tested in mouse/monkeys before give to humans, so there less complications right of the bat) - what needs to happen now is for them to deliver this treatment to Covid-19 paitents direct to the lungs to reduce the spread and kill of the virus as it develops in the lungs. When the virus gets into the lungs thats when pietents become very ill and start de-teriating leading to death. Very excited by TILLS, and Alan Green was spot on when he recommended by on Vax a few weeks ago.
The rest is in the posts below. do some dd. there will alot of rubbish from major boy (who is disrupting the board) - so filter him and you will see all good posts. hope that helps. glta.
Looking good here fellas, Covid-19 stocks on fire. watching this one :), some very good info/updates here. glta.
I must say, TILS is also looking good, their treatment/ drug has already shown Covid-19 cure capability (and approved by china fda, and shown to work in napels) and they have now got the patent out so they can start testing. Very easy to admininster and human ready - where as Roche drug treatment was used on mouse so cuases some complications when used in humans. TILS now has £10M cash, and ready for major moves ahead.
Looking good here fellas, Covid-19 stocks on fire. watching this one too, will add a little if given a good price :)
TILS is also looking good, their treatment/ drug has already shown Covid-19 cure capability (and approved by china fda, and shown to work in napels) and they have now got the patent out so they can start testing. Very easy to admininster and human ready - where as Roche drug treatment was used on mouse so cuases some complications when used in humans. TILS now has £10M cash, and ready for major moves ahead.
Baskam - excellent post/ info - thanks. Here is what i found (it was needle in haystak!)
Vaccine is critical, however not everyone will be vacinated (as the stats show for flu, where many people die every year!), therefore not everyone will get (or decide to go for) Corona vaccination (as they don't for flu), so treatment is needed now, and in the future, when someone has been tested with Corona (vaccination is too late at that stage), they will need treatment delivered direct to the lungs to kill off the virus/ slow the spread and allow the lungs to take in (use) the oxygen. TILS drug treatment does just that (and simliar has been succesful in treating people in china/ naples and get this has been approved by china fda to be used in china only).
See below the detials of what TILS senior management/ scientist are looking at, and why TILS could be trading very high to the current low levels, with oustanding broker target of £4 before Covid-19 development. Novel virus/ disease needs a novel treatment (only 2 other companies have IL-6R level treatement (Roche is one of them), and TILS have 2 distinct advantages as can be applied direct to the lungs, and is human use ready which means less impact on the human immuine system)
Tiziana, meanwhile, will start assessing the drug in patients as soon as is practicable and will administer TZLS-501 using its proprietary formulation technology.
It said the features of its drug candidate should provide it with distinct advantages other anti-IL-6R mAbs such as Actemra and Kevzara in treating severely affected COVID-19 patients.
The aforementioned advantages are TZLS-501s dual mechanism of action to inhibit signalling by the membrane-bound and soluble IL-6 receptors along with the rapid depletion of circulating IL-6 cytokine, a major cause of lung damage.
We are excited to move forward with our clinical development plan to expedite evaluation in patients as soon as possible", said Tiziana's chief executive Dr Kunwar Shailubhai.
Gabriele Cerrone, chairman, added that Tiziana only became aware of the potential of its anti-IL6R mAb after people in Naples with lung problems caused by coronavirus started to respond to treatment with Actemra.
We are sitting on one of best anti-IL6R monoclonal antibodies on the market but had no idea it could be used for Covid-19 complications on the respiratory system as no-one had ever tried it before.
https://www.proactiveinvestors.co.uk/companies/news/917034/small-cap-movers-tiziana-life-sciences-doubles-in-value-as-it-develops-inhaler-to-treat-coronavirus-patients-917034.html
''Not just that, Tiziana’s treatment may have a number of advantages over the competition – not least the inhaler method used to get the drug to the affected area. Currently, life-saving antibodies are administered intravenously''
What they are using to treat Covid - does not work as not tested for Covid - see note below, noted by someone (in usa) who has seen the use of the malaria drug.../ and reports already suggest it has not real effect as poeple contineu to die.
''The malaria drug is nasty,my husband took it whilst in Navy, it made everyone who took it on board have alot paranoia, and hallucinations. As well as vile headaches.. its use was not advised in more recent years with better newer meds for malaria. So why have it in this trial.. I hope were not doing TRUMPS work for him.. China and Italy tried it briefly to see if it had any benefit. They quickly found it did not. Even the WTO have said so''
Very good info by Baskam.
Well researched- thank you! Agree. Vaccine is not the be all and end all .
As you quite rightly mentioned, a lot of people still die from around the world by not having been treated by vaccine-preventable diseases.
(I attach some data from an online publication in collaboration with Oxford University) on attitudes towards vaccination, showing that in other parts of the world it is culturally not seen as agreeable to some.
https://ourworldindata.org/vaccination
The facts speak for themselves.
Therefore, even with a vaccine being made available in the long-term, this drug will still have market continuity for decades to come and more importantly will also able to treat any other mutations of CO-VID 19 if they manifest.
don't worry, it won't leave under £3, and then it will only move if it shareholders feel it adds value, and the some increase.
with covid drug treatment, then won't move, as it relates uk/ eu as much as usa. Also that is their last priority right now - you can see from the faces of TILS CEO and chief scientist officers that that they are working flat out to get this out becuase as experts they know they are sitting on a gold mine (found treatment effective by accident, its like its aleady tested, and drug is ready for direct human use, rather than mouse/ money first which was others have done or are doing - this is huge huge advanatage for TILS)
fantastic job on ncyt, remeber when it was around 50/70p from 20p.... and amount of rubbish we were getting. The more research, i do following submission of the drug/treatment patent the more i am finding it as compelling buy and hold for huge gains, think it will go ballastic as soon as previous rights issue clears (based on volume this should be done very soon, if not already). Fully funded from here on.
markets to open (so we can buy Tils, hope so :)
Tiziana Life Sciences doubles in value with potential treatment for coronavirus complications on the cards.Link below.
https://www.thisismoney.co.uk/money/investing/article-8204653/SMALL-CAP-MOVERS-Tiziana-Life-Sciences-doubles-value.html
Leddach....wish we all had crystal ...bal :). However, the cystal ball is here, do your research and you will get clarity. my view is it does not matter what the price does in the short term, what matters is underlining research and opp. TILS found out that their drug technology works by accident, and realised they are sitting on gold mine, even they are suprised and working full time on this now, as dast as they can. The fact they are in tallks for various gov agencies is a clue, and he fact couple of senior boi scientist have already pushed drugs to approval is another sign they will not let this go. So sometimes, the crystal ball is there, but we don;t use it - people need to get out if their own way. And when i see one liners. like it was supposed to go up, what happend, too much, why is going down etc (when a stock is up 60%, and has shown to zoom 250% in a few days, why was that?) - it amazes me, these are people (we are all like this) that say later - wish they had crystal ball. by that time its too late :) - for goodness sakeet it develop (much more info to come)
Corona has a mjaor pps impact on KAT, yet this does not impact KAT directly in any way. hence been buying at these levels. bakc over £4, before major gold production. buy/ hold, for mjaor gains ahead.
Baskam - excellent post/ info - thanks.
Here is what i found (it was needle in haystak!)
Vaccine is critical, however not everyone will be vacinated (as the stats show for flu, where many people die every year!), therefore not everyone will get (or decide to go for) Corona vaccination (as they dont for flu), so treatment is need now, and on the future, when some has been tested with Corona (vaccination to late at that stage), will need treatment delivered direct to the lungs to kill off the virus/ slow the spread and allow the lungs to take in (use) the oxygen. TILS drug treatment does just that (and simliar has been succesful in treating people in china and get this has been approved by china fda to be used in china only).
see below the detials of TILS is looking at, and why TILS could be trading very high to the curren levels. Novel virus/ disease needs a novel treatment.
Tiziana, meanwhile, will start assessing the drug in patients as soon as is practicable and will administer TZLS-501 using its proprietary formulation technology.
It said the features of its drug candidate should provide it with distinct advantages other anti-IL-6R mAbs such as Actemra and Kevzara in treating severely affected COVID-19 patients.
The aforementioned advantages are TZLS-501s dual mechanism of action to inhibit signalling by the membrane-bound and soluble IL-6 receptors along with the rapid depletion of circulating IL-6 cytokine, a major cause of lung damage.
We are excited to move forward with our clinical development plan to expedite evaluation in patients as soon as possible", said Tiziana's chief executive Dr Kunwar Shailubhai.
Gabriele Cerrone, chairman, added that Tiziana only became aware of the potential of its anti-IL6R mAb after people in Naples with lung problems caused by coronavirus started to respond to treatment with Actemra.
We are sitting on one of best anti-IL6R monoclonal antibodies on the market but had no idea it could be used for Covid-19 complications on the respiratory system as no-one had ever tried it before.
MMs have taken off the weakhands as they always do.
MMs kept doing it ncyt, again and again :)
MMs did with SNG at 30p, now 60p
MMs did with GDR...at 20p, now 40p
MMS will do with TILS at 70p.....(200p)
So no suprise there then...
Don't worry about delist off aim, the shares will only double when moves across to Nas, plus there is no shareholder approbal, and now with Covid drug treatment in the pipeline it will most likley not happen. :)
TILS aslo has another key drug in phase2, and now have £10M cash. SO why shoudl the pps stay at 60p. It was trading to 200p+ 2 years ago. so you buyers are getting these at low end, given all other Covid stocks have moved much higher, TILS drug is easy to deliver and has a couple of distinct advantages over others, therefore expect multiple of current pps regardless.
In the end the downside is limited (20%), upside 200%. take your pick. how many missed on ncyt on mis-information. it was not long ago. where £4 was impossible/ silly number, yet there sales are under £20m, and the mkt cap £200 - ask your self why. Well, Tills treatment will be needed for years to come to help illiminate infections in people that woud otherwise certianly die (liek you are seeing today - nothing is there to help them once the infection reaches the lungs!)
do some proper research fellas....
thier treatment for Covid-19, could also be tailored for Covid-20, or 21 if new strains of the virus develop (which some scientist have predicted is possible now). This is very powerful statement from TILS. The CEO also said Covid-19 has caught them by surpise, and they have been very busy over the last 3 weeks. So how far are they?...it sounds like as soon as patent is accepted, they will be UK/USA hospitals and deliver the treatment to critically ill people, so there is some hope for them. Currently, 90% die when they get to this stage.
It looks like the CEO is personally enagaged with devopment/lobby for TILS Covid treatment, and has had direct experience from previous outbreaks. Only this time they have the goods 9the actula drug) in hand (drug technology was aquired in 2017 from a swiss co) for a different purpose, but fits in with Covid 100%, and hence they have made this their top business priority.
There are few other points I picked up, which i will try to hughlight later. Looks like like a home run from here. They are ahead of SNG which helps control breathing, where is TILS clears the actual infection in the lungs, therefore not only helping the lungs to consume oxygen but also reducing the spread of the virus cells that acually go on to kill other parts of the body (i.e. the organs).
Feeling very positive, and feel broker target will be met soon or later.
It had great run to 165p four weeks ago, and now the co has $10m cash, and has filed the patent (this has to be done first before they release their treatment - it is a must, and proves they are serious and ready to go!). Therefore, expect over £2 on patent acceptance/ approval, and over £4 as teh treat the first list of patients in the feild.
Nyct at 70p....was crazy weeks ago.....:) ..... $4+ yesterday. And that was a Covid test.....TILS is cure/ treatment. Indication that it has been used succesfully in China, and TILS treatment has a couple of distinct advantages overs others. Hence why TILS pushing forwad as they are. Happy to put the house on this, pps is still low, can't go much lower (limited), upside multi bags. and we love multi bags. :)
looking very good, enjoy the ride :) hold a boat load. have a nice weekend
who missed the boat, ignore them and do your own research.There is alot of info, and company and ceo are straight up.
Best to filter the one line deramper/ better people. You can tell very quickly who they are - there is alot pain in their one liners/ words.